The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients

INTRODUCTION: With the emergence of SARS-CoV-2 mutant strains, especially the epidemic of Omicron, it continues to evolve to strengthen immune evasion. Omicron BQ. 1 and XBB pose a serious threat to the current COVID-19 vaccine (including bivalent mRNA vaccine for mutant strains) and COVID-19-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Min, Ding, Ping, Luan, Guangxin, Du, Ting, Deng, Shanshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027911/
https://www.ncbi.nlm.nih.gov/pubmed/36960047
http://dx.doi.org/10.3389/fcimb.2023.1141274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027911/
https://www.ncbi.nlm.nih.gov/pubmed/36960047
http://dx.doi.org/10.3389/fcimb.2023.1141274

Ejemplares similares